A. Al-salem, M. Alshammari, H. Hassan, A. Alazami, and F. Alkuraya, Weaver syndrome and defective cortical development: A rare association, American Journal of Medical Genetics Part A, vol.84, issue.1, pp.225-227, 2013.
DOI : 10.1002/ajmg.a.35660

D. Bodian, J. Mccutcheon, P. Kothiyal, K. Huddleston, R. Iyer et al., Germline Variation in Cancer-Susceptibility Genes in a Healthy, Ancestrally Diverse Cohort: Implications for Individual Genome Sequencing, PLoS ONE, vol.265, issue.4, p.94554, 2014.
DOI : 10.1371/journal.pone.0094554.s002

T. Cha, B. Zhou, W. Xia, Y. Wu, C. Yang et al., Akt-Mediated Phosphorylation of EZH2 Suppresses Methylation of Lysine 27 in Histone H3, Science, vol.310, issue.5746, pp.306-310, 2005.
DOI : 10.1126/science.1118947

M. Coulter-mackie and L. Gagnier, Spectrum of mutations in the arylsulfatase A gene in a Canadian DNA collection including two novel frameshift mutations, a new missense mutation (C488R) and an MLD mutation (R84Q) in cis with a pseudodeficiency allele, Molecular Genetics and Metabolism, vol.79, issue.2, pp.91-98, 2003.
DOI : 10.1016/S1096-7192(03)00077-5

D. Meglio, T. Kratochwil, C. Vilain, N. Loche, A. Vitobello et al., Ezh2 Orchestrates Topographic Migration and Connectivity of Mouse Precerebellar Neurons, Science, vol.339, issue.6116, pp.204-207, 2013.
DOI : 10.1126/science.1229326

T. Ernst, A. Chase, J. Score, C. Hidalgo-curtis, C. Bryant et al., Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders, Nature Genetics, vol.8, issue.8, pp.722-726, 2010.
DOI : 10.1016/j.molcel.2008.10.016

B. Freeman, A. Hoon, . Jr, S. Breiter, and A. Hamosh, Pachygyria in Weaver Syndrome, American Journal of Medical Genetics, vol.88, issue.4, pp.395-397, 1999.
DOI : 10.1002/(SICI)1096-8628(19991008)86:4<395::AID-AJMG16>3.0.CO;2-L

W. Gibson, R. Hood, S. Zhan, D. Bulman, A. Fejes et al., Mutations in EZH2 Cause Weaver Syndrome, The American Journal of Human Genetics, vol.90, issue.1, pp.110-118, 2012.
DOI : 10.1016/j.ajhg.2011.11.018

P. Guglielmelli, F. Biamonte, J. Score, C. Hidalgo-curtis, F. Cervantes et al., EZH2 mutational status predicts poor survival in myelofibrosis, Blood, vol.118, issue.19, pp.5227-5234, 2011.
DOI : 10.1182/blood-2011-06-363424

V. Grossmann, U. Bacher, A. Kohlmann, V. Artusi, H. Klein et al., EZH2 mutations and their association with PICALM-MLLT10 positive acute leukaemia, British Journal of Haematology, vol.25, issue.3, pp.387-390, 2012.
DOI : 10.1111/j.1365-2141.2011.08986.x

C. Huffman, D. Mccandless, R. Jasty, J. Matloub, H. Robinson et al., Weaver syndrome with neuroblastoma and cardiovascular anomalies, American Journal of Medical Genetics, vol.99, issue.3, pp.252-255, 2001.
DOI : 10.1002/1096-8628(2001)9999:9999<::AID-AJMG1169>3.0.CO;2-L

P. Joshi, E. Carrington, L. Wang, C. Ketel, E. Miller et al., Dominant Alleles Identify SET Domain Residues Required for Histone Methyltransferase of Polycomb Repressive Complex 2, Journal of Biological Chemistry, vol.283, issue.41, pp.27757-27766, 2008.
DOI : 10.1074/jbc.M804442200

W. Kim, G. Bird, T. Neff, G. Guo, M. Kerenyi et al., Targeted disruption of the EZH2???EED complex inhibits EZH2-dependent cancer, Nature Chemical Biology, vol.259, issue.10, pp.643-650, 2013.
DOI : 10.1073/pnas.1002713107

E. Kim, M. Kim, D. Woo, Y. Shin, J. Shin et al., Phosphorylation of EZH2 Activates STAT3 Signaling via STAT3 Methylation and Promotes Tumorigenicity of Glioblastoma Stem-like Cells, Cancer Cell, vol.23, issue.6, pp.839-852, 2013.
DOI : 10.1016/j.ccr.2013.04.008

S. Knutson, T. Wigle, N. Warholic, C. Sneeringer, C. Allain et al., A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells, Nature Chemical Biology, vol.8, pp.890-896, 2012.
DOI : 10.1038/nm.2651

S. Knutson, N. Warholic, T. Wigle, C. Klaus, C. Allain et al., Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2, Proceedings of the National Academy of Sciences, vol.110, issue.19, pp.7922-7927, 2013.
DOI : 10.1073/pnas.1303800110

S. Kudithipudi, C. Lungu, P. Rathert, N. Happel, and A. Jeltsch, Substrate Specificity Analysis and Novel Substrates of the Protein Lysine Methyltransferase NSD1, Chemistry & Biology, vol.21, issue.2, pp.226-237, 2014.
DOI : 10.1016/j.chembiol.2013.10.016

A. Kuzmichev, K. Nishioka, H. Erdjument-bromage, P. Tempst, and D. Reinberg, Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein, Genes & Development, vol.16, issue.22, pp.2893-2905, 2002.
DOI : 10.1101/gad.1035902

S. Lee, Z. Li, Z. Wu, M. Aau, P. Guan et al., Context-Specific Regulation of NF-??B Target Gene Expression by EZH2 in Breast Cancers, Molecular Cell, vol.43, issue.5, pp.798-810, 2011.
DOI : 10.1016/j.molcel.2011.08.011

P. Lewis, M. Muller, M. Koletsky, F. Cordero, S. Lin et al., Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma, Science, vol.340, issue.6134, pp.857-861, 2013.
DOI : 10.1126/science.1232245

K. Lund, P. Adams, and M. Copland, EZH2 in normal and malignant hematopoiesis, Leukemia, vol.27, issue.1, pp.44-49, 2014.
DOI : 10.1038/leu.2013.288

C. Majer, J. L. Scott, M. Knutson, S. Kuntz, K. Keilhack et al., A687V EZH2 is a gain-of-function mutation found in lymphoma patients, FEBS Letters, vol.285, issue.19, pp.3448-3451, 2012.
DOI : 10.1016/j.febslet.2012.07.066

H. Makishima, A. Jankowska, R. Tiu, H. Szpurka, Y. Sugimoto et al., Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies, Leukemia, vol.24, issue.10, pp.1799-1804, 2010.
DOI : 10.1038/ng.518

M. Mccabe, A. Graves, G. Ganji, E. Diaz, W. Halsey et al., Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27), Proceedings of the National Academy of Sciences, vol.109, issue.8, pp.2989-2994, 2012.
DOI : 10.1073/pnas.1116418109

M. Mccabe, H. Ott, G. Ganji, S. Korenchuk, C. Thompson et al., EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations, Nature, vol.22, issue.7427, pp.108-112, 2012.
DOI : 10.1038/nature11606

G. Mirzaa, R. Conway, K. Gripp, T. Lerman-sagie, D. Siegel et al., Megalencephaly-capillary malformation (MCAP) and megalencephaly-polydactyly-polymicrogyria-hydrocephalus (MPPH) syndromes: Two closely related disorders of brain overgrowth and abnormal brain and body morphogenesis, American Journal of Medical Genetics Part A, vol.102, issue.2, pp.269-291, 2012.
DOI : 10.1002/ajmg.a.34402

R. Morin, N. Johnson, T. Severson, A. Mungall, J. An et al., Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin, Nature Genetics, vol.22, issue.2, pp.181-185, 2010.
DOI : 10.1038/ng.518

P. Ntziachristos, A. Tsirigos, P. Van-vlierberghe, J. Nedjic, T. Trimarchi et al., Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia, Nature Medicine, vol.12, issue.2, pp.298-301, 2012.
DOI : 10.1038/leu.2011.93

H. Ott, A. Graves, M. Pappalardi, M. Huddleston, W. Halsey et al., A687V EZH2 Is a Driver of Histone H3 Lysine 27 (H3K27) Hypertrimethylation, Molecular Cancer Therapeutics, vol.13, issue.12, pp.3062-3073, 2014.
DOI : 10.1158/1535-7163.MCT-13-0876

A. Pengelly, O. Copur, H. Jackle, A. Herzig, and J. Muller, A Histone Mutant Reproduces the Phenotype Caused by Loss of Histone-Modifying Factor Polycomb, Science, vol.339, issue.6120, pp.698-699, 2013.
DOI : 10.1126/science.1231382

J. Pereira, S. Sansom, J. Smith, M. Dobenecker, A. Tarakhovsky et al., Ezh2, the histone methyltransferase of PRC2, regulates the balance between self-renewal and differentiation in the cerebral cortex, Proceedings of the National Academy of Sciences, vol.107, issue.36, pp.15957-15962, 2010.
DOI : 10.1073/pnas.1002530107

Q. Qiao, Y. Li, Z. Chen, M. Wang, D. Reinberg et al., The Structure of NSD1 Reveals an Autoregulatory Mechanism Underlying Histone H3K36 Methylation, Journal of Biological Chemistry, vol.286, issue.10, pp.8361-8368, 2011.
DOI : 10.1074/jbc.M110.204115

S. Sanulli, J. N. Teissandier, A. Ancelin, K. Portoso, M. Caron et al., Jarid2 Methylation via the PRC2 Complex Regulates H3K27me3 Deposition during Cell Differentiation, Jarid2 Methylation via the PRC2 Complex Regulates H3K27me3 Deposition during Cell Differentiation, pp.769-783, 2015.
DOI : 10.1016/j.molcel.2014.12.020
URL : https://hal.archives-ouvertes.fr/hal-01110498

K. Sarma, R. Margueron, A. Ivanov, V. Pirrotta, and D. Reinberg, Ezh2 Requires PHF1 To Efficiently Catalyze H3 Lysine 27 Trimethylation In Vivo, Molecular and Cellular Biology, vol.28, issue.8, pp.2718-2731, 2008.
DOI : 10.1128/MCB.02017-07

D. Schwarz, S. Varum, M. Zemke, A. Schöler, A. Baggiolini et al., Ezh2 is required for neural crest-derived cartilage and bone formation, Development, vol.141, issue.4, pp.867-877, 2014.
DOI : 10.1242/dev.094342

C. Sneeringer, M. Scott, K. Kuntz, S. Knutson, R. Pollock et al., Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas, Proceedings of the National Academy of Sciences, vol.107, issue.49, pp.20980-20985, 2010.
DOI : 10.1073/pnas.1012525107

H. Taal, S. Pourcain, B. Thiering, E. Das, S. Mook-kanamori et al., Common variants at 12q15 and 12q24 are associated with infant head circumference, Nature Genetics, vol.22, issue.5, pp.532-538, 2012.
DOI : 10.1016/j.neurobiolaging.2006.12.012

J. Tan, Y. Yan, X. Wang, Y. Jiang, and H. Xu, EZH2: biology, disease, and structure-based drug discovery, Acta Pharmacologica Sinica, vol.8, issue.2, pp.161-174, 2014.
DOI : 10.1016/j.molcel.2007.01.017

K. Tatton-brown, S. Hanks, E. Ruark, A. Zachariou, S. Duarte et al., Germline mutations in the oncogene EZH2 cause Weaver syndrome and increased human height, Oncotarget, vol.2, issue.12, pp.1127-1133, 2011.
DOI : 10.18632/oncotarget.385

K. Tatton-brown, A. Murray, S. Hanks, J. Douglas, R. Armstrong et al., mutations: Clarifying the clinical phenotype, American Journal of Medical Genetics Part A, vol.84, issue.12, pp.2972-2980, 2013.
DOI : 10.1002/ajmg.a.36229

K. Tatton-brown and N. Rahman, Overgrowth Genes, Similarities and Differences, American Journal of Medical Genetics Part C: Seminars in Medical Genetics, vol.9, issue.2, pp.86-91, 2013.
DOI : 10.1002/ajmg.c.31359

S. Tomatsu, A. Montaño, V. Dung, J. Grubb, and W. Sly, Mutations and polymorphisms in GUSB gene in mucopolysaccharidosis VII (Sly Syndrome), Human Mutation, vol.4, issue.Pt 2, pp.511-519, 2009.
DOI : 10.1002/humu.20828

G. Van-aller, M. Pappalardi, H. Ott, E. Diaz, M. Brandt et al., Long Residence Time Inhibition of EZH2 in Activated Polycomb Repressive Complex 2, ACS Chemical Biology, vol.9, issue.3, pp.622-629, 2014.
DOI : 10.1021/cb4008748

L. Wang, J. Q. Lee, J. Su, I. Ge, and K. , Histone H3K27 methyltransferase Ezh2 represses Wnt genes to facilitate adipogenesis, Proceedings of the National Academy of Sciences, vol.107, issue.16, pp.7317-7322, 2010.
DOI : 10.1073/pnas.1000031107

D. Weaver, C. Graham, I. Thomas, and D. Smith, A new overgrowth syndrome with accelerated skeletal maturation, unusual facies, and camptodactyly, The Journal of Pediatrics, vol.84, issue.4, pp.547-552, 1974.
DOI : 10.1016/S0022-3476(74)80675-X

A. Wood, T. Esko, J. Yang, S. Vedantam, T. Pers et al., Defining the role of common variation in the genomic and biological architecture of adult human height, Nature Genetics, vol.52, issue.11, pp.1173-1186, 2014.
DOI : 10.1093/nar/gkr988

D. Yap, J. Chu, T. Berg, M. Schapira, S. Cheng et al., Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation, Blood, vol.117, issue.8, pp.2451-2459, 2011.
DOI : 10.1182/blood-2010-11-321208

M. Yasuda, J. Shabbeer, S. Benson, M. I. Burnett, R. Desnick et al., Fabry disease: Characterization of ?-galactosidase A double mutations and the D313Y plasma enzyme pseudodeficiency allele, Human Mutation, vol.10, issue.6, pp.486-492, 2003.
DOI : 10.1002/humu.10275

S. Zaidi, M. Choi, H. Wakimoto, L. Ma, J. Jiang et al., De novo mutations in histone-modifying genes in congenital heart disease, Nature, vol.366, issue.7453, pp.220-223, 2013.
DOI : 10.1038/nature12141

J. Zhang, L. Ding, L. Holmfeldt, G. Wu, S. Heatley et al., The genetic basis of early T-cell precursor acute lymphoblastic leukaemia, Nature, vol.19, issue.7380, pp.157-163, 2012.
DOI : 10.1038/nature10725